Buck Wealth Strategies’s Strata Critical Medical Inc SRTA Stock Holding History

Buck Wealth Strategies’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63K	Buy	+500	New	+$2.63K	﹤0.01%	823

Other funds holding SRTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

Buck Wealth Strategies's SRTA Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 500 shares worth $2.63K. The stake represents ﹤0.01% of the portfolio and ranks #823 among its holdings.

50 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Buck Wealth Strategies held 500 shares of Strata Critical Medical Inc worth $2.63K as of Q2 2026.
Strata Critical Medical Inc was a new Buck Wealth Strategies position in Q2 2026.
Strata Critical Medical Inc made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #823 holding.
50 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.